Fuhai Li

Dr. Fuhai Li

Institute for Informatics (I2), Department of Pediatrics, Washington University in St. Louis, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2009 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
FLFuhai Li
Fuhai Li
XZXiaobo Zhou
Xiaobo Zhou
Jinwen MaJinwen Ma
Jinwen Ma
SWStephen T. C. Wong
Stephen T. C. Wong
Automated cell segmentation and tracking are critical for quantitative analysis of cell cycle behavior using time-lapse fluorescence microscopy. However, the complex, dynamic cell cycle behavior poses new challenges to the existing image segmentation and tracking methods. This paper presents a fully automated tracking method for quantitative cell cycle analysis. In the proposed tracking method, we introduce a neighboring graph to characterize the spatial distribution of neighboring nuclei, and a novel dissimilarity measure is designed based on the spatial distribution, nuclei morphological appearance, migration, and intensity information. Then, we employ the integer programming and division matching strategy, together with the novel dissimilarity measure, to track cell nuclei. We applied this new tracking method for the tracking of HeLa cancer cells over several cell cycles, and the validation results showed that the high accuracy for segmentation and tracking at 99.5% and 90.0%, respectively. The tracking method has been implemented in the cell-cycle analysis software package, DCELLIQ, which is freely available.

9 October 2007 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
FLFuhai Li
Fuhai Li
XZXiaobo Zhou
Xiaobo Zhou
JZJinmin Zhu
Jinmin Zhu
Jinwen MaJinwen Ma
Jinwen Ma
Xudong HuangXudong Huang
Xudong Huang
SWStephen Tc Wong
Stephen Tc Wong
Background: High content screening (HCS)-based image analysis is becoming an important and widely used research tool. Capitalizing this technology, ample cellular information can be extracted from the high content cellular images. In this study, an automated, reliable and quantitative cellular image analysis system developed in house has been employed to quantify the toxic responses of human H4 neuroglioma cells exposed to metal oxide nanoparticles. This system has been proved to be an essential tool in our study. Results: The cellular images of H4 neuroglioma cells exposed to different concentrations of CuO nanoparticles were sampled using IN Cell Analyzer 1000. A fully automated cellular image analysis system has been developed to perform the image analysis for cell viability. A multiple adaptive thresholding method was used to classify the pixels of the nuclei image into three classes: bright nuclei, dark nuclei, and background. During the development of our image analysis methodology, we have achieved the followings: (1) The Gaussian filtering with proper scale has been applied to the cellular images for generation of a local intensity maximum inside each nucleus; (2) a novel local intensity maxima detection method based on the gradient vector field has been established; and (3) a statistical model based splitting method was proposed to overcome the under segmentation problem. Computational results indicate that 95.9% nuclei can be detected and segmented correctly by the proposed image analysis system. Conclusion: The proposed automated image analysis system can effectively segment the images of human H4 neuroglioma cells exposed to CuO nanoparticles. The computational results confirmed our biological finding that human H4 neuroglioma cells had a dose-dependent toxic response to the insult of CuO nanoparticles.

13 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
HZHeming Zhang
Heming Zhang
JFJiarui Feng
Jiarui Feng
AZAmanda Zeng
Amanda Zeng
PPPhilip R Payne
Philip R Payne
FLFuhai Li
Fuhai Li
Drug combinations targeting multiple targets/pathways are believed to be able to reduce drug resistance. Computational models are essential for novel drug combination discovery. In this study, we proposed a new simplified deep learning model, DeepSignalingSynergy , for drug combination prediction. Compared with existing models that use a large number of chemical-structure and genomics features in densely connected layers, we built the model on a small set of cancer signaling pathways, which can mimic the integration of multi-omics data and drug target/mechanism in a more biological meaningful and explainable manner. The evaluation results of the model using the NCI ALMANAC drug combination screening data indicated the feasibility of drug combination prediction using a small set of signaling pathways. Interestingly, the model analysis suggested the importance of heterogeneity of the 46 signaling pathways, which indicates that some new signaling pathways should be targeted to discover novel synergistic drug combinations.

22 April 2010 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
FLFuhai Li
Fuhai Li
XZXiaobo Zhou
Xiaobo Zhou
WHWanting Huang
Wanting Huang
CCChung-Che Chang
Chung-Che Chang
SWStephen Tc Wong
Stephen Tc Wong
Background: DNA copy number aberration (CNA) is very important in the pathogenesis of tumors and other diseases. For example, CNAs may result in suppression of anti-oncogenes and activation of oncogenes, which would cause certain types of cancers. High density single nucleotide polymorphism (SNP) array data is widely used for the CNA detection. However, it is nontrivial to detect the CNA automatically because the signals obtained from high density SNP arrays often have low signal-to-noise ratio (SNR), which might be caused by whole genome amplification, mixtures of normal and tumor cells, experimental noise or other technical limitations. With the reduction in SNR, many false CNA regions are often detected and the true CNA regions are missed. Thus, more sophisticated statistical models are needed to make the CNAs detection, using the low SNR signals, more robust and reliable. Results: This paper presents a conditional random pattern (CRP) model for CNA detection where much contextual cues are explored to suppress the noise and improve CNA detection accuracy. Both simulated and the real data are used to evaluate the proposed model, and the validation results show that the CRP model is more robust and reliable in the presence of noise for CNA detection using high density SNP array data, compared to a number of widely used software packages. Conclusions: The proposed conditional random pattern (CRP) model could effectively detect the CNA regions in the presence of noise.

15 December 2024 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
FLFuhai Li
Fuhai Li
Li LiuLi Liu
Li Liu
KWKai Wang
Kai Wang
Xiaoming LiuXiaoming Liu
Xiaoming Liu
ZZZhongming Zhao
Zhongming Zhao
In this editorial, we summarize the 2023 International Conference on Intelligent Biology and Medicine (ICIBM 2023) conference which was held on July 16–19, 2023 in Tampa, Florida, USA. We then briefly describe the nine research articles included in this special issue. ICIBM 2023 scientific program included four tutorials and workshops, four keynote lectures, four eminent scholars’ presentations, 11 concurrent scientific sessions, and a poster session. We had total of 88 scientific oral presentations, including 62 regular oral presentations and 26 flash talks, as well as 46 poster presentations. The topics of these presentations covered artificial intelligence (AI), data sciences, bioinformatics, computational biology, genomics, biomedical informatics, among others. This special issue included nine peer reviewed manuscripts selected from those submitted to our conference. These articles cover a range of topics on the methods and applications of ML and AI models in the biomedical domain.

20 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
LGLoreina Guo
Loreina Guo
KCKendall Cornick
Kendall Cornick
VXVincent Xu
Vincent Xu
THTianyao Hao
Tianyao Hao
MIMa. Xenia Garcia Ilagan
Ma. Xenia Garcia Ilagan
FLFuhai Li
Fuhai Li
Medulloblastoma (MB) is the most common malignant brain tumor in infants and children. Four molecular subtypes of MB are recognized: WNT, SHH, Group 3 (G3), and Group 4 (G4). Compared with WNT and SHH subtypes, G3 MBs exhibit significantly worse outcomes and higher metastatic rates, and there is no effective treatment yet. Moreover, G3 and G4 MBs are much more common in boys than girls, i.e., sex bias, which also plays important roles in cancer prognosis and drug response. However, the molecular mechanism of G3 remains unclear, and there are no well-identified biomarker genes associated with these phenotypes, i.e., worse survival rate, higher metastasis rate, and sex bias. In this exploratory study, we aim to identify potential biomarkers associated with the three phenotypes using integrative analysis of gene expression, methylation and copy number variation datasets. In the results, we identified a set of biomarker genes and linked them into a network signature. The network signature showed better performance in the separation of G3 MB patients into subtypes with a significant difference in terms of the three phenotypes. To identify potentially effective drugs for G3 MBs, a set of drugs with diverse targets were prioritized, which can potentially inhibit the network signature. These drugs or combinations thereof might be effective for G3 treatment.